ATGGF
Price:
$0.0008
Market Cap:
$156.13M
Actinogen Medical Limited is an Australian biotechnology firm specializing in the creation of treatments for neurological and neuropsychiatric conditions linked to abnormal brain cortisol levels. Their primary therapeutic candidate, Xanamem, functions as an inhibitor of the 11ß-HSD1 enzyme. Currently in Phase 2 clinical trials, Xanamem has shown the ability to engage its intended target within the central nervous system. Its development focuses on addressing Alzheimer's disease, cognitive impairment associated with depression, and the anxiety, sleep, and behavioral challenges seen in fragile X syndrome. Founded in 1999, the company, based in Sydney, Australia, operated as Actinogen Limited u...[Read more]
Industry
Biotechnology
IPO Date
2018-09-18
Stock Exchange
OTC
Ticker
ATGGF
According to Actinogen Medical Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.21. This represents a change of -97.21% compared to the average of -7.52 of the last 4 quarters.
The mean historical PE Ratio of Actinogen Medical Limited over the last ten years is -11.12. The current -0.21 PE Ratio has changed 88.91% with respect to the historical average. Over the past ten years (40 quarters), ATGGF's PE Ratio was at its highest in in the December 2024 quarter at -0.02. The PE Ratio was at its lowest in in the June 2021 quarter at -34.21.
Average
-11.12
Median
-7.79
Minimum
-45.61
Maximum
-1.03
Discovering the peaks and valleys of Actinogen Medical Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 904.93%
Maximum Annual PE Ratio = -1.03
Minimum Annual Increase = -80.79%
Minimum Annual PE Ratio = -45.61
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.69 | -56.67% |
| 2024 | -10.83 | 62.95% |
| 2023 | -6.65 | -25.61% |
| 2022 | -8.94 | -80.41% |
| 2021 | -45.61 | 904.93% |
| 2020 | -4.54 | 340.01% |
| 2019 | -1.03 | -80.79% |
| 2018 | -5.37 | -53.55% |
| 2017 | -11.56 | -3.17% |
| 2016 | -11.94 | 121.43% |
The current PE Ratio of Actinogen Medical Limited (ATGGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.39
5-year avg
-15.35
10-year avg
-11.12
Actinogen Medical Limited’s PE Ratio is greater than Nicox S.A. (-13.87), greater than Clara Technologies Corp. (-23.94), greater than Vicapsys Life Sciences, Inc. (-179.01), greater than IXICO plc (-4.08), greater than Alterity Therapeutics Limited (-6.28), greater than ZIVO Bioscience, Inc. (-2.34), greater than BioStem Technologies, Inc. (-2.83), less than MindMaze Therapeutics Holding S.A. (0), greater than Amplia Therapeutics Limited (-8.98), greater than Helix BioPharma Corp. (-35.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -13.87 | $29.17M | |
| -23.94 | $3.60M | |
| -179.01 | $46.94M | |
| -4.08 | $6.51M | |
| -6.28 | $76.13M | |
| -2.34 | $15.55M | |
| -2.83 | $56.62M | |
| 0 | $5.30M | |
| -8.98 | $44.14M | |
| -35.00 | $130.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinogen Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Actinogen Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Actinogen Medical Limited's PE Ratio?
How is the PE Ratio calculated for Actinogen Medical Limited (ATGGF)?
What is the highest PE Ratio for Actinogen Medical Limited (ATGGF)?
What is the 3-year average PE Ratio for Actinogen Medical Limited (ATGGF)?
What is the 5-year average PE Ratio for Actinogen Medical Limited (ATGGF)?
How does the current PE Ratio for Actinogen Medical Limited (ATGGF) compare to its historical average?